Background Eating disorder treatment is most successful when delivered at first onset, underscoring the importance of early intervention. Genetic factors may contribute to earlier
Large observational study from medical records with genetic association analyses, but lacks prospective design, randomization, and hard clinical outcomes; findings are descriptive and hypothesis-generating rather than confirmatory of treatment efficacy.
A narrative feature article reviewing the current state of evidence for immunometabolic approaches in psychiatry, identifying where signal exists versus where speculation predominates, and recommending pathways for translating emerging science into clinical practice.